Adding GLP-1 Agonists to the Personalized Treatment Plan

/

At Soma Bariatrics, we pride ourselves on staying at the forefront of innovation in obesity care. That’s why we now offer GLP-1 receptor agonists as part of our comprehensive catalogue of treatments. These groundbreaking medications are transforming the way we manage obesity and metabolic conditions.

What Are GLP-1 Agonists?

GLP-1 agonists, like semaglutide, mimic a hormone that regulates appetite and blood sugar levels. These medications help patients:

  • Feel full sooner and longer,

  • Control cravings,

  • Improve insulin sensitivity,
    resulting in effective and sustained weight loss.

How GLP-1 Agonists Fit Into a Personalized Approach

For some patients, GLP-1 agonists might be the ideal standalone solution, especially for those who prefer a non-invasive approach. For others, these medications can complement surgical or non-surgical options:

  • Pre-Surgery: Used as a neoadjuvant therapy to improve patient outcomes and reduce surgical risks.

  • Post-Surgery: As an adjuvant therapy to help maintain weight loss and metabolic improvements.

  • Alternative for Non-Surgical Patients: Perfect for individuals not ready or eligible for surgery but seeking significant weight loss.

By integrating GLP-1 agonists into our treatment plans, we provide more flexibility and better outcomes for our patients.